Ischemic stroke laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
Line 8: | Line 8: | ||
|+ | |+ | ||
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Blood test }} | ! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Blood test }} | ||
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF| | ! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Test result}} | ||
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Rationale}} | |||
|- | |- | ||
Line 14: | Line 15: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
To look for underlying infection (leukocytosis), [[thrombocytosis]] and [[thrombocytopenia|thrombocytopenia,]] [[polycythemia]] | To look for underlying infection (leukocytosis), [[thrombocytosis]] and [[thrombocytopenia|thrombocytopenia,]] [[polycythemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Lipid profile|'''Lipid profile''']] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Lipid profile|'''Lipid profile''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Increased [[LDL]], [[triglycerides]] and [[cholesterol]] increases risk for ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |Increased [[LDL]], [[triglycerides]] and [[cholesterol]] increases risk for ischemic stroke | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[PT|'''PT''']]'''/[[APTT]]/[[INR]]''' | | style="padding: 5px 5px; background: #F5F5F5;" |[[PT|'''PT''']]'''/[[APTT]]/[[INR]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying bleeding risk for anticoagulant administration | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying bleeding risk for anticoagulant administration | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[BUN|'''BUN''']]'''/[[Creatinine]]''' | | style="padding: 5px 5px; background: #F5F5F5;" |[[BUN|'''BUN''']]'''/[[Creatinine]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Renal function tests to look for underlying kidney disease | | style="padding: 5px 5px; background: #F5F5F5;" |Renal function tests to look for underlying kidney disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Serum [[Homocysteine|homocystein]] level''' | | style="padding: 5px 5px; background: #F5F5F5;" |'''Serum [[Homocysteine|homocystein]] level''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Increased levels associated with increased risk of thromboembolic event | | style="padding: 5px 5px; background: #F5F5F5;" |Increased levels associated with increased risk of thromboembolic event | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Basic metabolic panel|'''Basic metabolic panel''']] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Basic metabolic panel|'''Basic metabolic panel''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |To rule out electrolyte abnormalities which may mimic or complicate ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out electrolyte abnormalities which may mimic or complicate ischemic stroke | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[HbA1C|'''HbA1C''']] | | style="padding: 5px 5px; background: #F5F5F5;" |[[HbA1C|'''HbA1C''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Underlying [[diabetes mellitus]], major risk factor for ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |Underlying [[diabetes mellitus]], major risk factor for ischemic stroke | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |'''Blood glucose levels''' | | style="padding: 5px 5px; background: #F5F5F5;" |'''Blood glucose levels''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Hyperglycemia]] is associated with poor prognosis of ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |[[Hyperglycemia]] is associated with poor prognosis of ischemic stroke | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac enzymes|'''Cardiac enzymes''']] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac enzymes|'''Cardiac enzymes''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying [[Coronary heart disease|coronary artery disease]] | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying [[Coronary heart disease|coronary artery disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Pregnancy test|'''Pregnancy test''']] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Pregnancy test|'''Pregnancy test''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |To rule out pregnancy in female patients with ischemic stroke as t-PA is a class C agent. | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out pregnancy in female patients with ischemic stroke as t-PA is a class C agent. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
|} | |} |
Revision as of 19:45, 17 November 2016
Ischemic Stroke Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ischemic stroke laboratory findings On the Web |
American Roentgen Ray Society Images of Ischemic stroke laboratory findings |
Risk calculators and risk factors for Ischemic stroke laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Laboratory Findings
Labortary tests may help determine the risk factors complications of ischemic stroke. Blood tests which may be performed include:
Blood test | Test result | Rationale |
---|---|---|
Complete blood count |
To look for underlying infection (leukocytosis), thrombocytosis and thrombocytopenia, polycythemia |
|
Lipid profile | Increased LDL, triglycerides and cholesterol increases risk for ischemic stroke | |
PT/APTT/INR | To rule out underlying bleeding risk for anticoagulant administration | |
BUN/Creatinine | Renal function tests to look for underlying kidney disease | |
Serum homocystein level | Increased levels associated with increased risk of thromboembolic event | |
Basic metabolic panel | To rule out electrolyte abnormalities which may mimic or complicate ischemic stroke | |
HbA1C | Underlying diabetes mellitus, major risk factor for ischemic stroke | |
Blood glucose levels | Hyperglycemia is associated with poor prognosis of ischemic stroke | |
Cardiac enzymes | To rule out underlying coronary artery disease | |
Pregnancy test | To rule out pregnancy in female patients with ischemic stroke as t-PA is a class C agent. |